• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓移植中的经颈静脉肝活检

Transjugular liver biopsy in BMT.

作者信息

Carreras E, Grañena A, Navasa M, Bruguera M, Marco V, Sierra J, Tassies M D, García-Pagán J C, Martí J M, Bosch J

机构信息

Postgraduate School of Hematology Farreras Valenti, Hospital Clínic, Barcelona, Spain.

出版信息

Bone Marrow Transplant. 1993 Jan;11(1):21-6.

PMID:8431707
Abstract

With the aim of evaluating liver disturbances after BMT in 76 patients, the hepatic venous pressure gradient was measured and a transvenous liver biopsy was performed through the jugular vein. Catheterization was successful in 71 patients (93%). In 11 cases the procedure was performed twice, yielding a total number of 82 studies. In five (6%) liver biopsies were non-evaluable. Complications were rare (7%), minor and reversible. As a result of this procedure, the diagnosis was modified in 45%, with both the diagnosis and treatment being modified in 30% of patients. Veno-occlusive disease (VOD) was histologically demonstrated in 15 out of 26 patients (58%) in whom this complication was suspected and in two out of 33 (6%) in whom it was not. Acute GVHD of the liver was confirmed in 15 out of the 35 patients (43%) in whom this complication was suspected and in four of 24 (17%) in whom it was not. The hepatic venous pressure gradient was significantly higher in VOD than in liver GVHD. Whereas 14/17 (82%) patients with VOD had a gradient pressure higher than 9 mmHg, no patient with GVHD had a gradient above this value. We conclude that transjugular liver biopsy is an effective, safe, and useful technique to evaluate BMT related liver dysfunction.

摘要

为评估76例骨髓移植(BMT)后的肝脏紊乱情况,测量了肝静脉压力梯度,并通过颈静脉进行了经静脉肝活检。71例患者(93%)插管成功。11例患者进行了两次该操作,共进行了82次研究。5例(6%)肝活检无法评估。并发症罕见(7%),程度较轻且可逆转。通过该操作,45%的患者诊断得以修正,30%的患者诊断和治疗均得以修正。在怀疑有该并发症的26例患者中,15例(58%)经组织学证实患有肝静脉闭塞病(VOD),在未怀疑有该并发症的33例患者中,2例(6%)患有该病。在怀疑有该并发症的35例患者中,15例(43%)经证实患有肝脏急性移植物抗宿主病(GVHD),在未怀疑有该并发症的24例患者中,4例(17%)患有该病。VOD患者的肝静脉压力梯度显著高于肝脏GVHD患者。14/17(82%)例VOD患者的梯度压力高于9 mmHg,而GVHD患者中没有患者的梯度压力高于此值。我们得出结论,经颈静脉肝活检是评估BMT相关肝功能障碍的一种有效、安全且有用的技术。

相似文献

1
Transjugular liver biopsy in BMT.骨髓移植中的经颈静脉肝活检
Bone Marrow Transplant. 1993 Jan;11(1):21-6.
2
Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.经颈静脉肝内门体分流术(TIPS)用于治疗骨髓移植后严重的肝静脉闭塞病。
Bone Marrow Transplant. 2000 May;25(9):987-92. doi: 10.1038/sj.bmt.1702386.
3
[Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].[肝活检在异基因造血干细胞移植后肝功能障碍管理中的应用]
Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3062-6.
4
Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management.腹腔镜肝活检用于评估血液系统恶性肿瘤患者的肝功能障碍:改变治疗管理的有用工具。
Bone Marrow Transplant. 1996 Apr;17(4):655-62.
5
Chronic cholestasis in patients after allogeneic bone marrow transplantation: several diseases are often associated.异基因骨髓移植后患者的慢性胆汁淤积:常与多种疾病相关。
Bone Marrow Transplant. 1995 Aug;16(2):261-5.
6
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.经颈静脉肝内门体分流术治疗骨髓移植后严重肝静脉闭塞病
Hepatology. 1996 Sep;24(3):588-91. doi: 10.1002/hep.510240321.
7
Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.肝素预防接受骨髓移植儿童肝静脉闭塞病的II期试验。
Bone Marrow Transplant. 1996 Jul;18(1):185-91.
8
Liver dysfunction in the early post-bone marrow transplant period.骨髓移植后早期的肝功能障碍
Cas Lek Cesk. 1996 May 15;135(10):295-8.
9
Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.异基因骨髓移植后肝静脉闭塞病中可溶性白细胞介素-2受体水平升高。
Transplantation. 1995 Dec 15;60(11):1293-9.
10
Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
Bone Marrow Transplant. 1995 Sep;16(3):473-8.

引用本文的文献

1
Acute liver failure due to herpes simplex viral hepatitis diagnosed by skin lesions and blood tests: a case report.皮肤病变和血液检查诊断的单纯疱疹病毒性肝炎引起的急性肝衰竭:一例报告。
J Med Case Rep. 2023 Aug 10;17(1):338. doi: 10.1186/s13256-023-04083-w.
2
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions.窦性阻塞综合征中的肝静脉压力梯度:诊断价值及与组织学病变的关联
JHEP Rep. 2022 Aug 17;4(11):100558. doi: 10.1016/j.jhepr.2022.100558. eCollection 2022 Nov.
3
Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.
肝移植物抗宿主病与异基因造血干细胞移植受者的不良生存相关。
Am J Hematol. 2019 Oct;94(10):1072-1080. doi: 10.1002/ajh.25575. Epub 2019 Jul 29.
4
A noninvasive diagnostic approach using per-rectal portal scintigraphy for sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation.一种使用直肠门静脉闪烁扫描术对异基因造血细胞移植后窦性阻塞综合征进行无创诊断的方法。
Bone Marrow Transplant. 2020 Feb;55(2):470-472. doi: 10.1038/s41409-019-0537-x. Epub 2019 May 14.
5
No free rides: management of toxicities of novel immunotherapies in ALL, including financial.概无免费乘车:包括财务毒性在内的新型免疫疗法治疗 ALL 的毒性管理。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):25-34. doi: 10.1182/asheducation-2018.1.25.
6
No free rides: management of toxicities of novel immunotherapies in ALL, including financial.概无免费乘车:包括财务毒性在内的新型免疫疗法治疗 ALL 的毒性管理。
Blood Adv. 2018 Nov 27;2(22):3393-3403. doi: 10.1182/bloodadvances.2018020198.
7
Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.肝移植术后肝静脉闭塞病的管理:一例病例报告并文献复习
Medicine (Baltimore). 2018 Jun;97(24):e11076. doi: 10.1097/MD.0000000000011076.
8
Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality.重症监护病房中接受同种异体造血干细胞移植的危重症患者:死亡率预后因素的系统评价和荟萃分析。
Bone Marrow Transplant. 2018 Oct;53(10):1233-1241. doi: 10.1038/s41409-018-0181-x. Epub 2018 Apr 27.
9
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.儿童患者窦状隙阻塞综合征/静脉阻塞性疾病的诊断和严重程度标准:来自欧洲血液和骨髓移植学会的新分类。
Bone Marrow Transplant. 2018 Feb;53(2):138-145. doi: 10.1038/bmt.2017.161. Epub 2017 Jul 31.
10
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.成人患者窦性阻塞综合征/静脉闭塞性疾病的修订诊断和严重程度标准:欧洲血液和骨髓移植学会的新分类
Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16.